Search for: "Glaxosmithkline PLC"
Results 161 - 180
of 203
Sorted by Relevance
|
Sort by Date
16 Jun 2008, 12:00 pm
GlaxoSmithKline PLC, No. 07-5045, 2008 U.S. [read post]
28 Feb 2011, 2:10 am
Bloomberg News reported, “The ruling is a victory for the four companies that supply vaccines for the US market — Wyeth, GlaxoSmithKline Plc, Merck & Co. and Sanofi-Aventis SA. [read post]
3 Jun 2008, 12:59 am
GlaxoSmithKline PLC
U.S. [read post]
26 Feb 2009, 1:44 pm
It turns out, however, that GlaxoSmithKline PLC -- the drug company that makes Avandia -- had some (improper) advanced notice of the Nissen and Wolski NEJM article and (surprise, surprise) the drug company tried to do something about it. [read post]
11 May 2012, 2:09 pm
Oral arguments regarding GlaxoSmithKline PLC’s sales reps were heard before the Supreme Court just last month. [read post]
21 Sep 2010, 6:00 am
GlaxoSmithKline, PLC, et al., 2010 U.S. [read post]
31 Mar 2022, 10:50 am
The Justice Department will reportedly probe at least a dozen pharmaceutical companies such as Gilead Sciences Inc, Johnson & Johnson and GlaxoSmithKline PLC’s ViiV Healthcare. [read post]
15 Jul 2013, 10:00 pm
This message was driven home even more strongly last week with the news from China that the Chinese government had found evidence that the UK pharmaceutical giant GlaxoSmithKline PLC (GSK) was involved in bribery and corruption of Chinese doctors. [read post]
28 Oct 2010, 5:37 am
” The Wall Street Journal (9/24, Mundy, Dooren, et al) also notes that GlaxoSmithKline PLC, the maker of Avandia, expects minimal sales of the drug once the rules take effect. [read post]
7 May 2010, 1:07 pm
GlaxoSmithKline PLC, 349 F.3d 1373, 1382 (Fed. [read post]
31 Jul 2012, 8:24 am
Motion Denied Brief Overview: In April 2012, GlaxoSmithKline plc (“GSK”) made an unsolicited offer for HGSI at $13 per share which was rejected by the Board. [read post]
28 Oct 2010, 5:36 am
” The Wall Street Journal (9/24, Mundy, Dooren, et al) also notes that GlaxoSmithKline PLC, the maker of Avandia, expects minimal sales of the drug once the rules take effect. [read post]
12 Jan 2012, 10:59 am
(which is now a fully-owned subsidiary of GlaxoSmithKline PLC, but at the time of the events in issue was the world’s largest private manufacturer of dermatology products) and its former chairman and CEO, Charles Stiefel. [read post]
23 Sep 2008, 9:34 pm
. -- is as safe and effective as Wellbutrin XL -- made by Canada's Biovail Corp. and sold by GlaxoSmithKline PLC. [read post]
28 Oct 2010, 5:34 am
” The Wall Street Journal (9/24, Mundy, Dooren, et al) also notes that GlaxoSmithKline PLC, the maker of Avandia, expects minimal sales of the drug once the rules take effect. [read post]
29 Apr 2010, 2:27 pm
In her April 28, 2010 piece, "Critics cite Avandia in pushing FDA safety reforms", Reuters reporter Lisa Richwine provided us the reactions of the FDA and Representative DeLauro to the this testimony by Senator Grassley in the context of the current debate about the safety of the diabetes drug Avandia: Two drug safety reviewers have recommended that [GlaxoSmithKline Plc diabetes drug Avandia] come off the market after concluding it was more dangerous to the heart than… [read post]
28 Oct 2010, 5:32 am
” The Wall Street Journal (9/24, Mundy, Dooren, et al) also notes that GlaxoSmithKline PLC, the maker of Avandia, expects minimal sales of the drug once the rules take effect. [read post]
8 Mar 2012, 3:34 am
., GlaxoSmithKline PLC and others that have disclosed investigations for possible FCPA breaches. [read post]
9 May 2013, 3:31 am
In Glaxo, Humana Medical Plan Inc. and Humana Insurance Company (collectively, Humana) sued GlaxoSmithKline LLC and GlaxoSmithKline PLC (collectively, GSK) for reimbursement of expenses Humana incurred from injuries its MA members sustained from use of GSK’s type 2 diabetes drug, Avandia. [read post]
25 Jan 2009, 2:36 pm
Investors punished Crucell after Pfizer bid was reported, driving its stock down 9.6 percent to 15.51 euros in Amsterdam trading. 130,000 Employees The combined company will have 130,000 employees, and its annual revenue would be 55 percent more than the world's second- biggest drugmaker, London-based GlaxoSmithKline Plc, which has said it will focus on smaller purchases in the year ahead. [read post]
